Submission Details
| 510(k) Number | K972929 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 08, 1997 |
| Decision Date | October 20, 1997 |
| Days to Decision | 73 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K972929 is an FDA 510(k) clearance for the N ANTISERUM TO HUMAN ALBUMIN, a Albumin, Antigen, Antiserum, Control (Class II — Special Controls, product code DCF), submitted by Behring Diagnostics, Inc. (Westwood, US). The FDA issued a Cleared decision on October 20, 1997, 73 days after receiving the submission on August 8, 1997. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5040.
| 510(k) Number | K972929 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 08, 1997 |
| Decision Date | October 20, 1997 |
| Days to Decision | 73 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | DCF — Albumin, Antigen, Antiserum, Control |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5040 |